HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $454 | -4.2% | 11,874 | -9.7% | 0.04% | -5.4% |
| Q2 2023 | $474 | +33.9% | 13,152 | +41.8% | 0.04% | +42.3% |
| Q1 2023 | $354 | -16.3% | 9,277 | +24.9% | 0.03% | -25.7% |
| Q4 2022 | $423 | -99.9% | 7,427 | -35.4% | 0.04% | -16.7% |
| Q3 2022 | $455,000 | +3.4% | 11,505 | +15.0% | 0.04% | +5.0% |
| Q2 2022 | $440,000 | +42.9% | 10,000 | +29.4% | 0.04% | +300.0% |
| Q1 2022 | $308,000 | +52.5% | 7,726 | +53.7% | 0.01% | +42.9% |
| Q4 2021 | $202,000 | – | 5,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |